Related Experiment Video

Updated: Oct 21, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

3.8K

Insights Into Genetics and Pathophysiology of Arrhythmogenic Cardiomyopathy

Brenda Gerull1, Andreas Brodehl2

  • 1Comprehensive Heart Failure Center (CHFC), Department of Medicine I, University Clinic Würzburg, Am Schwarzenberg 15, 97078, Würzburg, Germany. gerull_b@ukw.de.

Current Heart Failure Reports
|September 3, 2021
PubMed

Insights

Arrhythmogenic cardiomyopathy (ACM) is a genetic heart condition causing dangerous arrhythmias and sudden cardiac death. Recent advances improve risk assessment and identify new therapeutic targets for personalized medicine.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Arrhythmogenic cardiomyopathy (ACM) is a genetic disease causing ventricular arrhythmias and sudden cardiac death (SCD) in young adults.
  • Mutations in genes for cellular junctions are found in about half of ACM patients, but disease presentation and outcomes vary significantly.
  • Currently, no targeted drug treatments are available for ACM.

Purpose of the Study:

  • To review recent advancements in clinical risk stratification for ACM.
  • To explore the genetic basis and pathophysiological mechanisms underlying ACM.
  • To outline novel therapeutic targets for personalized ACM treatment.

Main Methods:

  • Review of current literature on ACM genetics, pathophysiology, and clinical management.
  • Analysis of desmosomal and other protein interactions in ACM pathogenesis.
  • Discussion of signaling pathways and inflammation in ACM.
  • Identification of potential therapeutic targets based on genetic and preclinical research.

Main Results:

  • The desmosome is central to ACM, but mutations in other structural proteins expand the genetic spectrum and offer new insights.
  • Understanding of ACM pathogenesis is enhanced by exploring signaling pathways and inflammation.
  • Genetic discoveries and preclinical research are paving the way for personalized medicine approaches.
  • Advances in risk stratification are improving patient management.

Conclusions:

  • ACM pathogenesis involves complex genetic and molecular pathways beyond the desmosome.
  • Personalized medicine, targeting specific mutations and pathways, holds promise for future ACM treatment.
  • Further research into signaling pathways and inflammation is crucial for developing effective therapies.
Abstract

Keywords:
Arrhythmogenic cardiomyopathyCardiovascular geneticsDesmosomesDilated cardiomyopathyJunctionsSudden cardiac death

More Related Videos

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia09:36

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

Published on: December 22, 2023

1.4K
An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

5.9K

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
96
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
129
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
1.3K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
83
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
121
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
907